Patients who were prescribed Dupixent (dupilumab) to treat eczema, asthma, or other inflammatory conditions often trusted that the medication was safe and effective. For many, it appeared to improve symptoms at first. But some patients later received a far more serious diagnosis: cutaneous T-cell lymphoma (CTCL), a rare type of cancer that can closely resemble eczema in its early stages. 

Lawsuits are now being filed across the United States alleging that Dupixent may not only be linked to the development or progression of CTCL, but may also delay proper diagnosis by masking its symptoms.  

If you or a loved one were diagnosed with lymphoma after using Dupixent, you and your family may be eligible to file a lawsuit and pursue compensation.  

Find out whether you qualify or start your claim today by calling the lawyers at Hissey Mulderig & Friend toll-free at 1-866-806-8117, or by filling out our free case evaluation form, located on the right side this page. 

What Is Dupixent and Why Is It Prescribed?

Dupixent is a biologic medication approved to treat several chronic conditions, including: 

• Moderate to severe eczema (atopic dermatitis)  
• Asthma  
• Chronic sinus conditions with nasal polyps  
• Other inflammatory diseases  

It works by targeting specific pathways in the immune system that drive inflammation. While this mechanism can reduce symptoms for some patients, it may also affect how the body responds to underlying conditions that were not properly diagnosed at the outset. 

The Link Between Dupixent and Lymphoma

At the center of the litigation is cutaneous T-cell lymphoma (CTCL), a rare cancer that affects the skin. CTCL is often difficult to diagnose because it can look nearly identical to eczema in its early stages. 

This overlap has created a serious concern. Some patients who were believed to have eczema were prescribed Dupixent, when in reality they may have already had early-stage lymphoma. Others allege that Dupixent may have contributed to the progression or worsening of the disease. 

Lawsuits filed against the manufacturers of Dupixent have alleged that: 

• Dupixent may mask symptoms of CTCL, delaying accurate diagnosis  
• The drug may alter immune responses in a way that allows cancer to progress  
• Manufacturers failed to provide adequate warnings about these risks  

Because early detection is critical in cancer cases, any delay in diagnosis can have serious consequences. 

How CTCL Can Be Misdiagnosed as Eczema

One of the most important issues in Dupixent lawsuits is the misdiagnosis of CTCL for eczema. 

CTCL symptoms may include: 

• Persistent rashes or patches on the skin  
• Red, scaly, or itchy areas  
• Skin lesions that do not respond to standard treatments  
• Worsening symptoms over time  

These symptoms often resemble eczema, which is far more common. As a result, patients may be treated for eczema for months or even years before receiving the correct diagnosis. 

When Dupixent is prescribed under these circumstances, it may give the appearance of improvement while the underlying cancer continues to develop. 

Who May Be Eligible to File a Dupixent Lawsuit?

You may be eligible to file a lawsuit if: 

• You were prescribed Dupixent for eczema or a related condition  
• You were later diagnosed with cutaneous T-cell lymphoma or another lymphoma  
• Your diagnosis was delayed, changed, or occurred after using the medication  
• You experienced worsening symptoms while using Dupixent  

In many cases, patients did not know they had lymphoma until after beginning treatment. Others were initially diagnosed with eczema and only later learned that their condition was cancer. 

An attorney can review your medical history, timeline of symptoms, and diagnosis to determine whether your situation meets the criteria for a Dupixent lawsuit. 

What Dupixent Lawsuits Allege

Dupixent lawsuits are generally filed as product liability claims. These cases focus on whether the drug manufacturers provided adequate warnings about known or reasonably foreseeable risks. 

Claims being investigated include: 

• Failure to warn patients and physicians about lymphoma risks  
• Failure to study or disclose potential links between Dupixent and CTCL  
• Marketing the drug for conditions that may be misdiagnosed without sufficient safeguards  

These lawsuits seek compensation for medical expenses, lost income, pain and suffering, and other damages associated with delayed cancer diagnosis or progression. 

Why Timing Matters in These Cases

In cases involving cancer, timing is critical. A delayed diagnosis can mean: 

• More advanced disease at the time of detection  
• More aggressive or extensive treatment  
• Reduced treatment options  
• Greater long-term health consequences  

If Dupixent played a role in delaying diagnosis or allowing the disease to progress, that delay may be central to a legal claim. 

Speaking with an attorney sooner rather than later can help preserve evidence and ensure that your case is evaluated properly. 

What to Do If You Were Diagnosed With Lymphoma After Dupixent

If you find yourself in this situation, you do not need to gather medical records or prove your case before reaching out. What matters most is understanding whether your experience may be connected to the issues being raised in Dupixent litigation. 

An experienced pharmaceutical liability attorney can: 

• Review your diagnosis and treatment timeline  
• Determine whether Dupixent exposure may be relevant  
• Explain your legal options clearly  
• Handle the process of obtaining medical records and documentation  

Taking the first step by contacting an attorney does not commit you to filing a lawsuit. It simply allows you to understand your options. 

Find Out Whether You Qualify for a Dupixent Lawsuit

Patients who were diagnosed with lymphoma after using Dupixent are now coming forward to contact an attorney to help them explore their legal options.  

If you were treated for eczema and later diagnosed with CTCL or another form of lymphoma, you may be eligible to file a lawsuit and receive compensation if Dupixent contributed to a delayed diagnosis or progression of cancer.  

Find out whether you qualify or to start your claim today by contacting the law firm of Hissey Mulderig & Friend. There is no charge for a consultation, and no legal fees unless we successfully recover damages in your case. 

You can reach us by calling our office toll-free at 1-866-806-8117, or by completing our free case evaluation form, located at the top of this page.